We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$128M
AUM Growth
+$13.5M
Cap. Flow
-$1.11M
Cap. Flow %
-0.87%
Top 10 Hldgs %
26.71%
Holding
1,141
New
64
Increased
222
Reduced
212
Closed
55

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$189K
2
EQIX icon
Equinix
EQIX
+$93.7K
3
ALGN icon
Align Technology
ALGN
+$77.8K
4
MU icon
Micron Technology
MU
+$65.9K
5
AVGO icon
Broadcom
AVGO
+$63.2K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$949K
2
DLR.PRH.CL
Digital Realty Trust, Inc.
DLR.PRH.CL
+$296K
3
JNJ icon
Johnson & Johnson
JNJ
+$274K
4
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$144K
5
TSM icon
TSMC
TSM
+$95.4K

Sector Composition

Rank Sector Weight
1 Technology 28.37%
2 Healthcare 12.61%
3 Financials 10.22%
4 Consumer Staples 7.19%
5 Consumer Discretionary 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSN icon
826
Tyson Foods
TSN
$20.2B
$2K ﹤0.01%
+23
New +$1.42K
UMC icon
827
United Microelectronic
UMC
$48.9B
$2K ﹤0.01%
+1,027
New +$1.89K
UNFI icon
828
United Natural Foods
UNFI
$3.01B
$2K ﹤0.01%
156
– –
URI icon
829
United Rentals
URI
$71.1B
$2K ﹤0.01%
15
– –
VC icon
830
Visteon
VC
$2.77B
$2K ﹤0.01%
30
– –
VONV icon
831
Vanguard Russell 1000 Value ETF
VONV
$20.4B
$2K ﹤0.01%
44
– –
VOOG icon
832
Vanguard S&P 500 Growth ETF
VOOG
$25.4B
$2K ﹤0.01%
60
– –
VRTX icon
833
Vertex Pharmaceuticals
VRTX
$121B
$2K ﹤0.01%
9
– –
WF icon
834
Woori Financial
WF
$15.8B
$2K ﹤0.01%
+50
New +$1.95K
WH icon
835
Wyndham Hotels & Resorts
WH
$5.46B
$2K ﹤0.01%
35
+9
+35% +$455
WPP icon
836
WPP
WPP
$4.04B
$2K ﹤0.01%
42
+6
+17% +$334
WSM icon
837
Williams-Sonoma
WSM
$26.7B
$2K ﹤0.01%
68
– –
WTS icon
838
Watts Water Technologies
WTS
$11.5B
$2K ﹤0.01%
24
– –
XPH icon
839
State Street SPDR S&P Pharmaceuticals ETF
XPH
$469M
$2K ﹤0.01%
+44
New +$1.79K
EGRX
840
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2K ﹤0.01%
+40
New +$1.78K
DOOR
841
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$2K ﹤0.01%
32
– –
CPE
842
DELISTED
Callon Petroleum Company
CPE
$2K ﹤0.01%
29
– –
MDRX
843
DELISTED
Veradigm Inc. Common Stock
MDRX
$2K ﹤0.01%
220
– –
NATI
844
DELISTED
National Instruments Corp
NATI
$2K ﹤0.01%
50
– –
RFP
845
DELISTED
Resolute Forest Products Inc.
RFP
$2K ﹤0.01%
253
-3
-1% -$25
LHCG
846
DELISTED
LHC Group LLC
LHCG
$2K ﹤0.01%
19
– –
WDR
847
DELISTED
Waddell & Reed Financial, Inc.
WDR
$2K ﹤0.01%
144
– –
HDS
848
DELISTED
HD Supply Holdings, Inc.
HDS
$2K ﹤0.01%
47
– –
APC
849
DELISTED
Anadarko Petroleum
APC
$2K ﹤0.01%
49
– –
TCF
850
DELISTED
TCF Financial Corporation Common Stock
TCF
$2K ﹤0.01%
+60
New +$2.6K
32 33
34
35 36

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Front Row Advisors held 1,141 positions worth $128M, up 12% from $115M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Front Row Advisors's Q1 2019 filing shows 64 new, 222 increased, 212 reduced and 55 closed positions. Its largest new stake was Vanguard Value ETF: 539 shares worth $58K. The largest sale was Biogen, an estimated $949K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Front Row Advisors's largest Q1 2019 buy was Vanguard Value ETF: 539 shares worth $58K.
  • Front Row Advisors added most to NVIDIA in Q1 2019, an estimated $189K increase.
  • Front Row Advisors's biggest Q1 2019 reduction was Biogen, cutting an estimated $949K.
  • Front Row Advisors fully exited Digital Realty Trust, Inc. in Q1 2019, selling an estimated $296K.
  • Front Row Advisors's ten largest holdings make up 27% of its $128M portfolio in Q1 2019.
  • Front Row Advisors opened 64 new positions and closed 55 in Q1 2019.
  • Front Row Advisors's portfolio value rose 12% quarter-over-quarter to $128M.

Based on Front Row Advisors's 13F filing for Q1 2019, filed 16 May 2019.